The US Food and Drug Administration issued an Emergency Use Authorization (EUA) to use the Johnson & Johnson COVID-19 Vaccine on Feb. 27, 2021. HHSC added the vaccine to the Medicaid and Children’s Health Insurance Program (CHIP) formularies as a payable pharmacy benefit effective Feb. 27.
|Johnson & Johnson||COVID-19 Vaccine EUA||59676-0580-05|
|Johnson & Johnson||COVID-19 Vaccine EUA||59676-0580-15|
To learn more, refer to the VDP COVID-19 vaccine page.